Transaction #6308 · Form 4 · 0000899140-25-001256
Benitec Biopharma Inc. · Purchase · Common stock, par value $0.0001 per share
Benitec Biopharma Inc. · Transacted November 7, 2025 · Filed November 10, 2025
What does this filing report?
An SEC Form 4 filing for Benitec Biopharma Inc. records a purchase involving Common stock, par value $0.0001 per share on November 7, 2025. The reported quantity was 730,370. The filing date is November 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Benitec Biopharma Inc.
- Company CIK
- 0001808898
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 730,370
- Reported price
- 13.5 · See footnotes
- Reference value
- 9,859,995
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 9,538,175
- Ownership description
- See footnotes
- SEC acceptance time
- Nov 10, 2025, 9:51 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- SUVRETTA CAPITAL MANAGEMENT, LLC ↗
Director · 10% owner
CIK 0001569064
- Cowen Aaron ↗
10% owner
CIK 0001869640
- Averill Master Fund, Ltd. ↗
Director · 10% owner
CIK 0001939329
- Averill Madison Master Fund, Ltd. ↗
Director · 10% owner
CIK 0002021243
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Notes are included on Exhibit 99.1.
- F2
- Notes are included on Exhibit 99.1.
- F3
- Notes are included on Exhibit 99.1.
Remarks
Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.